Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Tradegate
20.11.24
08:03 Uhr
1,760 Euro
-0,031
-1,73 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,7441,81014:41
1,7581,81014:42

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
MiJIUYUAN GENE Entry Fee $2,537.33, Introduces FOSUN PHARMA, ALI HEALTH as Cornerstone Investors13
04.11.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION14
01.11.FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK13
30.10.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY1
30.10.Fosun Pharma Announces 2024Q3 Financial Results849Revenue Exceed RMB30.9 Billion with R&D Expenditure RMB3.9 Billion Continuing to Consolidate its Dominant Position In The fields of Breast Cancer and Lung Cancer ...
► Artikel lesen
29.10.FOSUN PHARMA (02196): NOTIFICATION LETTER TO REGISTERED SHAREHOLDER - NEW ARRANGEMENTS ON DISSEMINATION OF CORPORATE COMMUNICATIONS6
29.10.FOSUN PHARMA (02196): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDER AND REQUEST FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS8
29.10.FOSUN PHARMA (02196): 2024 THIRD QUARTERLY REPORT6
23.10.FOSUN PHARMA (02196): JOINT ANNOUNCEMENT - PROGRESS UPDATE IN RELATION TO THE PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF ...11
17.10.FOSUN PHARMA (02196): DATE OF BOARD MEETING16
15.10.Nature's Sunshine Products, Inc. (NASDAQ:NATR) Major Shareholder Fosun Pharmaceutical Shanghai Sells 1,300 Shares9
14.10.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION10
10.10.FOSUN PHARMA (02196): ARTICLES OF ASSOCIATION10
10.10.FOSUN PHARMA (02196): ANNOUNCEMENT - CHANGES TO THE REGISTERED CAPITAL AND ARTICLES OF ASSOCIATION4
27.09.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION25
27.09.FOSUN PHARMA (02196): ARTICLES OF ASSOCIATION 9
27.09.FOSUN PHARMA (02196): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTION19
27.09.FOSUN PHARMA (02196): POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 27 SEPTEMBER 2024 AND ELECTION ...10
23.09.FOSUN PHARMA (02196): JOINT ANNOUNCEMENT - PROGRESS UPDATE IN RELATION TO THE PRE-CONDITIONAL PRIVATISATION OF HENLIUS BY FOSUN NEW MEDICINE BY WAY OF ...9
23.09.FOSUN PHARMA (02196): NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK4
Seite:  Weiter >>
64 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2